Jamal Zidan

Safed, Z 13000, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Cancer Risk in Clinically Recognized Celiac Disease: A Nationwide Propensity-Matched Cohort Study.

Cancer Risk in Clinically Recognized Celiac Disease: A Nationwide Propensity-Matched Cohort Study.

Journal: Medical sciences (Basel, Switzerland)

Published: May 27, 2026

Surgery After Induction Therapy for Cervical Esophageal Cancer: A Systematic Review and Proposed Multidisciplinary Selection Framework.

Surgery After Induction Therapy for Cervical Esophageal Cancer: A Systematic Review and Proposed Multidisciplinary Selection Framework.

Journal: Cancers

Published: May 03, 2026

Real-World Outcomes of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Single-Center Study.

Real-World Outcomes of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Single-Center Study.

Journal: Journal of clinical medicine

Published: April 28, 2026

Prognostic Impact and Postoperative Management Following Poor Pathological Response to Perioperative FLOT in Resectable Gastric and GEJ Adenocarcinoma: A Systematic Review and Meta-Analysis.

Prognostic Impact and Postoperative Management Following Poor Pathological Response to Perioperative FLOT in Resectable Gastric and GEJ Adenocarcinoma: A Systematic Review and Meta-Analysis.

Journal: Journal of clinical medicine

Published: February 18, 2026

Comprehensive Genetic Analysis of Druze Provides Insights into Carrier Screening.

Comprehensive Genetic Analysis of Druze Provides Insights into Carrier Screening.

Journal: Genes

Published: February 18, 2023

Oncology Treatments during the COVID-19 Pandemic in Israel: the ONCOR Study.

Oncology Treatments during the COVID-19 Pandemic in Israel: the ONCOR Study.

Journal: The Israel Medical Association journal : IMAJ

Published: December 26, 2021

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

Journal: Human mutation

Published: October 30, 2017

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

Journal: Breast cancer research and treatment

Published: October 16, 2017

Unusually high prevalence of classical Kaposi's sarcoma in Druze Muslims of Northern Israel.

Unusually high prevalence of classical Kaposi's sarcoma in Druze Muslims of Northern Israel.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 24, 2017

Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel.

Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel.

Journal: Breast cancer research and treatment

Published: May 11, 2017

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry.

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry.

Journal: NPJ breast cancer

Published: March 01, 2017

Complications of dysgerminoma: meeting the health needs of patients in conflict zones.

Complications of dysgerminoma: meeting the health needs of patients in conflict zones.

Journal: BMJ case reports

Published: February 01, 2017

Showing 1-12 of 32

Last Updated: 09/26/2026